— Know what they know.
Not Investment Advice

STEK OTC

Stemtech Corporation
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -88.9% 1Y: -99.2% 3Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 50 · $216929 mcap · 1.94B float · 1.44% daily turnover · Short 95% of daily vol

Cash Flow Trends

Operating Cash Flow
-$601K +70.5% ▲
Capital Expenditures
$0 -100.0% ▼
Free Cash Flow
-$601K +70.5% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$141K +870.3% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$2M-$7M-$9M-$5M-$4M
Depreciation & Amort.$556K$326K$447K$660K$415K
Stock-Based Comp.$450K$1M$4M$439K$440K
Change in Working Capital$443K$973K-$336K$1M$1M
Other Non-Cash Items$11K$7M$3M$1M$934K
Operating Cash Flow-$267K-$2M-$1M-$2M-$601K
— Investing Activities —
Capital Expenditures-$12K$0$0$2$0
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0$0$0
Investing Cash Flow-$12K$0$0$0$0
— Financing Activities —
Net Debt Issuance$159K$3M$24K$2M$75K
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$314K-$190K$530K
Financing Cash Flow$159K$3M$339K$2M$1M
Net Change in Cash-$117K$695K-$696K-$18K$141K
Cash End of Period$133K$828K$132K$114K$255K
Free Cash Flow-$278K-$2M-$1M-$2M-$601K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms